Study of Lifileucel (LN-144), Autologous Tumor Infiltrating Lymphocytes, in the Treatment of Patients With Metastatic Melanoma
Completed · Phase 2
Conditions studied: Metastatic Melanoma
In brief
Prospective, interventional multicenter study evaluating adoptive cell therapy (ACT) via infusion of LN-144 (autologous TIL) followed by interleukin 2 (IL-2) after a nonmyeloablative lymphodepletion (NMA LD) preconditioning regimen.
Key facts
- Study ID
- NCT02360579
- Run by
- Iovance Biotherapeutics, Inc.
- People needed
- 220
- Starts
- 2015-09-24
- Expected to finish
- 2024-10-24
- Last updated by the study team
- 2026-03-25
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- The Angeles Clinic and Research Institute — Los Angeles, California, United States
- University of California Los Angeles - David Geffen School of Medicine - Westwood Rheumatology — Los Angeles, California, United States
- California Pacific Medical Center — San Francisco, California, United States
- University of Colorado Cancer Center — Aurora, Colorado, United States
- Yale Cancer Center — New Haven, Connecticut, United States
- University of Miami — Miami, Florida, United States
- Mount Sinai Comprehensive Cancer Center — Miami Beach, Florida, United States
- University of Florida Health Cancer Center — Orlando, Florida, United States
- University of South Florida H. Lee Moffitt Cancer Center and Research Institute — Tampa, Florida, United States
- Indiana University — Indianapolis, Indiana, United States
- James Graham Brown Cancer Center — Louisville, Kentucky, United States
- University of Minnesota, Masonic Cancer Center — Minneapolis, Minnesota, United States
- Atlantic Health System — Morristown, New Jersey, United States
- Rutgers University — New Brunswick, New Jersey, United States
- Roswell Park Cancer Institute — Buffalo, New York, United States
- New York University Langone Medical Center — New York, New York, United States
- Providence Cancer Center Oncology and Hematology Care Clinic — Portland, Oregon, United States
- Thomas Jefferson University — Philadelphia, Pennsylvania, United States
- University of Pittsburgh Medical Center - Hillman Cancer Center — Pittsburgh, Pennsylvania, United States
- Virginia Commonwealth University — Richmond, Virginia, United States
- Seattle Cancer Care Alliance — Seattle, Washington, United States
- Medical College of Wisconsin — Milwaukee, Wisconsin, United States
- Centre Léon Bérard — Lyon, Auvergne-Rhône-Alpes, France
- Centre Hospitalier Lyon Sud — Pierre-Bénite, Auvergne-Rhône-Alpes, France
- University of California San Diego Moores Cancer Center — La Jolla, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.